Albert Einstein College of Medicine has received a grant from the NIAID for a project called PROVIDENT to develop vaccines and therapies against emerging viruses. Led by Dr. Kartik Chandran, the project aims to focus on virus families to quickly create countermeasures during pandemics, learning from previous outbreaks like COVID-19. The grant will fund research on nairoviruses, hantaviruses, and paramyxoviruses. The goal is to work with academic, government, and industry teams to develop tools that can be easily adapted for different viruses. The ultimate aim is to improve global preparedness for future pandemics and quickly respond to emerging viral threats.
Source link
NIH funds new research to combat emerging viruses
